We are live on
!
Find out more
ACL
APEIRON Capital Ltd Portfolio holdings
AUM
$156M
1-Year Est. Return
183.17%
This Fund
S&P 500
This Quarter
Est. Return
-14.06%
1 Year Est. Return
+183.17%
3 Year Est. Return
+486.87%
5 Year Est. Return
+343.15%
10 Year Est. Return
–
AUM
$107M
AUM Growth
+$20.5M
(+24%)
Cap. Flow
+$42.2M
Cap. Flow
% of AUM
39.49%
Top 10 Holdings %
Top 10 Hldgs %
96.09%
Holding
14
New
9
Increased
2
Reduced
1
Closed
1
Avg Time Held Equity + Options
1.7
quarters
Top 10 Avg Time Held Equity + Options
2.2
quarters
Top 20 Avg Time Held Equity + Options
1.7
quarters
Avg Time Held Equity only
1.8
quarters
Top 10 Avg Time Held Equity only
2.2
quarters
Top 20 Avg Time Held Equity only
1.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
On Holding
ONON
|
+$8.74M |
| 2 |
Micron Technology
MU
|
+$8.58M |
| 3 |
Unity
U
|
+$6.95M |
| 4 |
Amazon
AMZN
|
+$5.39M |
| 5 |
Trip.com Group
TCOM
|
+$4.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$2.53M |
| 2 |
Summit Therapeutics
SMMT
|
+$1.62K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 39.72% |
| 2 | Healthcare | 23.21% |
| 3 | Technology | 17.07% |
| 4 | Financials | 14.15% |
| 5 | Miscellaneous | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
On Holding
ONON
$10.7B
| $33.9M | 31.69% |
996,052
+200,200
| +25% | +$8.74M |
2022 Q3
14 quarters
|
|
|
2
Summit Therapeutics
SMMT
$13.8B
| $24.8M | 23.21% |
1,309,141
-100
| -0% | -$1.62K |
2025 Q2
3 quarters
|
|
3
Qfin Holdings
QFIN
$796M
| $13.3M | 12.46% |
1,032,055
+4,600
| +0.4% | +$70.7K |
2025 Q1
4 quarters
|
|
|
4
Micron Technology
MU
$1.2T
| $7.4M | 6.92% |
+21,900
| New | +$8.58M |
2026 Q1
0 quarters
|
|
|
5
Unity
U
$20.1B
| $5.5M | 5.14% |
+250,600
| New | +$6.95M |
2026 Q1
0 quarters
|
|
|
6
Amazon
AMZN
$2.71T
| $5.1M | 4.77% |
+24,500
| New | +$5.39M |
2026 Q1
0 quarters
|
|
7
KraneShares CSI China Internet ETF
KWEB
$4.47B
| $3.55M | 3.32% |
125,000
| – | – |
2025 Q4
1 quarter
|
|
|
8
Trip.com Group
TCOM
$24.4B
| $3.49M | 3.26% |
+70,000
| New | +$4.08M |
2026 Q1
0 quarters
|
|
9
TSMC
TSM
$2.52T
| $2.97M | 2.78% |
+8,800
| New | +$3.03M |
2026 Q1
0 quarters
|
|
10
FTAI Aviation
FTAI
$16.9B
| $2.69M | 2.52% |
+11,000
| New | +$2.91M |
2026 Q1
0 quarters
|
|
11
Synopsys
SNPS
$93.6B
| $2.38M | 2.22% |
+6,000
| New | +$2.71M |
2026 Q1
0 quarters
|
|
12
Robinhood
HOOD
$103B
| $1.8M | 1.69% |
+26,000
| New | +$2.28M |
2026 Q1
0 quarters
|
|
13
CALL
Pinduoduo
PDD
$111B
| $4.2K | ﹤0.01% |
+83,000
| New | +$8.72M |
2026 Q1
0 quarters
|
|
|
14
Vertiv
VRT
$97.6B
| – | – |
-15,600
| Closed | -$2.53M | – |
|
Similar funds
RWC
SC
JAA
BF
FLP
RB
CP
CWM
APEIRON Capital Ltd's Q1 2026 Portfolio in Review
As of Q1 2026, APEIRON Capital Ltd held 14 positions worth $107M, up 24% from $86.5M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
APEIRON Capital Ltd deployed $42.2M of net new capital in Q1 2026, opening 9 new positions and adding to 2 existing holdings. Its largest new stake was Micron Technology: 21,900 shares worth $7.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 43% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Summit Therapeutics, an estimated $1.62K trimmed.
- APEIRON Capital Ltd's largest Q1 2026 buy was Micron Technology: 21,900 shares worth $7.4M.
- APEIRON Capital Ltd added most to On Holding in Q1 2026, an estimated $8.74M increase.
- APEIRON Capital Ltd's biggest Q1 2026 reduction was Summit Therapeutics, cutting an estimated $1.62K.
- APEIRON Capital Ltd fully exited Vertiv in Q1 2026, selling an estimated $2.53M.
- APEIRON Capital Ltd's ten largest holdings make up 96% of its $107M portfolio in Q1 2026.
- APEIRON Capital Ltd opened 9 new positions and closed 1 in Q1 2026.
- APEIRON Capital Ltd's portfolio value rose 24% quarter-over-quarter to $107M.
Based on APEIRON Capital Ltd's 13F filing for Q1 2026, filed 22 Apr 2026.